Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Terminated 4Active not recruiting 3Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Lymphoma, Non-Hodgkin 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Lymphoma 3Leukemia, Biphenotypic, Acute 3Hodgkin Disease 3Burkitt Lymphoma 3Lymphoma, Mantle-Cell 2Leukemia, Myelomonocytic, Juvenile 2Anemia, Refractory, with Excess of Blasts 2Teratoma 1Seminoma 1Sarcoma, Myeloid 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Nonseminomatous germ cell tumor 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Multi-centric Castleman's Disease 1Medulloblastoma 1Macular dystrophy, corneal type 1 1

Interventions

Etoposide 5Cyclophosphamide 5Vincristine 4Methotrexate 4Doxorubicin 4Cytarabine 4pegaspargase 3merphos 3dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Leucovorin 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3Calcium Dobesilate 3venetoclax 2prednylidene 2exifone 2deltacortene 2calaspargase pegol 2azathiopurine 2Whole-Body Irradiation 2Thioguanine 2Tacrolimus 2Stem Cell Transplantation 2Specimen Handling 2Sirolimus 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Granulocyte Colony-Stimulating Factor × Clear all
NCT00792948 2026-05-29

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
97 enrolled 7 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03007147 2026-05-04

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Active not recruiting
475 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07541755 2026-04-21

PD1-VEN-CAG

Fujian Medical University Union Hospital

Phase 3 Active not recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡